Scottish scientists have discovered how to control a major anti-tumour gene that could lead to more effective chemotherapy. According to a report in the
Cancer Cell Journal, research conducted by the Universities of St Andrews and Dundee may eventually lead to the development of new cancer drugs.
The gene, called p53 and known as "the guardian of the genome", is damaged or switched off in most cancers. But the resrchers found that they could reboot it using two new biological compounds called "tenovins".
In a laboratory study, the academics found that these compounds could kick-start p53 by turning off enzymes called sirtuins. Sirtuins act like genetic switches and keep p53 under control, ensuring that the cells stay alive.
Dr Nick Westwood from the School of Chemistry at the University of St Andrews said, "This is a great example of what can be done by researchers from different disciplines collaborating. This programme has successfully combined skills in cell and cancer biology, biochemistry, genetics and chemistry to deliver compounds of genuine therapeutic interest."
He explained, "The approach that we used to identify the tenovins differs from the main approach used today in many pharmaceutical and biotech companies. The compounds were initially selected for study because they induced the required effect on whole cells as opposed to the use of purified proteins.
"The research team then figured out the details of how the observed effect occurred. Whilst other examples of our experimental approach are known, it is quite an achievement to get this far. Our choice of approach has been justified as we have shown that both of the tenovins work in a cancer model."
Given that faults in p53 function contribute to many types of cancer, the discovery of less toxic chemicals that can restore or amplify its power has enormous potential.
Dr Sonia Lain from Dundee University and joint author of the study said, "Our findings indicate that improved tenovin derivatives may have the potential to stop tumours and that their ability to switch on p53 contributes to this.
"We have found that tenovins work by inhibiting sirtuins. This is important, as it may facilitate further optimisation of the compounds."
The research was jointly funded by Cancer Research UK, the University of Dundee and Tenovus Scotland, a charity which supports medical research in Scottish Universities.
Source: University of St Andrews
Related stories:
Blood pressure drugs halt pancreatic cancer cell growth, researchers find
Researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia are inching closer to understanding how common blood pressure medications might help prevent the spread of pancreatic cancer. They have found in the laboratory that one type of pressure-lowering drug called an angiotensin receptor blocker inhibits pancreatic cancer cell growth and causes cell death.
Evidence now suggests eating soy foods in puberty protects against breast cancer
Evidence is growing from animal and human studies that genistein, a potent chemical found in soy, protects against development of breast cancer - but only if consumed during puberty, says a Georgetown University Medical Center researcher in the British Journal of Cancer published online today. The challenge now, she says, is for scientists to understand precisely why soy appears to provide a shield against the most common cancer in women.
Mouse model for mesothelioma reproduces human disease
Scientists have established a mouse model for human malignant mesothelioma (MM) that will provide valuable insight into cancer development and progression along with new directions for design of therapeutic strategies. The research, published by Cell Press in the March issue of
Cancer Cell, may eventually lead to a substantially improved outlook for patients with this devastating disease.
High zinc status in lung cells slows growth and induces DNA damage-induced gene expression
Researchers at the University of Maryland at College Park have discovered that Normal Human Bronchial Epithelial (NHBE) cells cultured in medium with elevated zinc level, at the high end of plasma zinc attainable by oral supplementation, demonstrated inhibition of cell growth, up-regulation of growth arrest and DNA damage-induced gene (Gadd45) mRNA and protein expression, and blockage of G2/M cell cycle progression.
Evolution of human genome's 'guardian' gives people unique protections from DNA damage
Human evolution has created enhancements in key genes connected to the p53 regulatory network – the so-called guardian of the genome – by creating additional safeguards in human genes to boost the network’s ability to guard against DNA damage that could cause cancer or a variety of genetic diseases, an international team of scientists led by Cincinnati Children’s Hospital Medical Center writes in the Jan. 22
Proceedings of the National Academy of Sciences.
You can teach an old dog new tricks: anti-malarial prevents cancer in mice
New data generated by a team of researchers from St Jude Children’s Research Hospital, Memphis, and Scripps Research Institute, Jupiter, have indicated that the antimalarial drug chloroquine effectively prevents cancer in mouse models of two distinct human cancer syndromes, Burkitt lymphoma and ataxia telangiectasia.
New study reveals for first time how BRCA1 mutations cause breast cancer
An international team of researchers led by Columbia University Medical Center’s Herbert Irving Comprehensive Cancer Center and Sweden’s Lund University has, for the first time, revealed how mutations in the BRCA1 gene lead to breast cancer. Findings show that one way BRCA1 mutations cause cancer is by knocking out a powerful tumor suppressor gene known as PTEN.
Ancient retroviruses spurred evolution of gene regulatory networks in humans and other primates
When ancient retroviruses slipped bits of their DNA into the primate genome millions of years ago, they successfully preserved their own genetic legacy. Today an estimated 8 percent of the human genetic code consists of endogenous retroviruses (ERVs)--the DNA remnants from these so-called "selfish parasites."
